Search for Clinical Trial Results
ANCA-associated Vasculitis - 103 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Rituximab Vasculitis Maintenance Study Condition:
|
Recruiting |
Study Name: Low-dose Glucocorticoid Vasculitis Induction Study Condition:
|
Recruiting |
Study Name: Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Condition: Vasculitis Date: 2005-08-09 Interventions: Drug: azathioprine azathioprine 2 mg/kg oral once daily, duration according to arm |
Completed |
Study Name: Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis Condition:
Date: 2006-02-16 Interventions: Drug: Rituximab |
Recruiting |
Study Name: Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Date: 2016-03-01 Interventions: Drug: Rituximab re-dosing dependent on interventional arm parameter. |
Recruiting |
Study Name: Differing Levels of Positive Anti-Neutrophil Cytoplasm Antibody (ANCA) Test and Their Correlation With Vasculitis or Malignancy or Chronic Inflammation Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Date: 2014-07-01 Interventions: Other: Follow-up Follow-up of of patients with borderline positive ANCA test results |
Completed |
Study Name: Efficacy Study of Two Treatments in the Remission of Vasculitis Condition:
Date: 2008-09-05 Interventions:
|
Completed |
Study Name: Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis Condition:
|
Not yet recruiting |
Study Name: Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis Condition:
|
Recruiting |
Study Name: Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) Condition:
Interventions: |